The Mediterranean diet has been linked to decreased risk of metabolic syndrome, diabetes, and CV events, but there is also criticism of these studies.
Diabetes Diagnosis: MODY or not MODY?
Have you ever treated a patient diagnosed with type 2 diabetes who doesn’t fit the usual body habitus?
Interesting T2DM: Weight Loss Device & Meds Update
Our October list of news and research includes FDA approval of a new weight loss device, a comparison of canagliflozin & glimepiride, and more.
Cannabinoid Compounds for Type 2 Diabetes
There are claims, ranging from anecdotal reports to experimental research, that cannabis and its derivative compounds have medicinal use for diabetes.
Why Do Insurance Companies Work Against Doctors?
If payors require patients to use particular businesses, it behooves them to ensure that these companies are doing their job and doing it right.
Bariatric Surgery in Diabetes Management
Is it time to add bariatric/metabolic surgery to diabetes treatment guidelines? What criteria should be used to select candidates for surgery?
Metformin: Cardioprotective in Type 1 Diabetes?
Can metformin’s cardioprotective effect also benefit patients with type 1 diabetes? Dr. Bobby Lazzara discusses a small study of 23 patients.
New Formulation to Deliver Insulin Orally
Researchers are now developing a new way to administer insulin orally with tiny vesicles that can deliver the medicine where it needs to go.
Bariatric Surgery: Long-Term Weight Loss Durability
Does bariatric surgery result in long-term maintenance of weight loss? Dr. Bobby Lazzara discusses a cohort study with 10-year and 4-year follow-up.
Medical Nutrition Therapy for Type 2 Diabetes
This Medical News Minute reviews the impact of a structured meal plan on the HbA1c and weight of patients with type 2 diabetes.
Industry Influence on Prescribing Rates
In this Medical News Minute, Dr. Bobby Lazzara looks at pharmacy industry-sponsored meals and rates of prescribing the promoted drug.
Endo News Roundup: T1 and T2 Diabetes Management
Three studies show the potential of an artificial pancreas & a less invasive glucose testing device and a 2-drug combo to improve glycemic measures.
Endo News Roundup: Managing HbA1c & CV Risks
New studies highlight which T2DM meds help reduce CV risks and, for metformin failure, the benefits of early intervention & a promising drug combo.
Interesting Endo: Sedentary Risks & Heart Health
Our August list of news and research includes research concerning a sedentary lifestyle, FDA updates, and imaging after thyroid cancer treatment.
By clicking Accept, you agree to become a member of the UBM Medica Community.